'Comparison of QR 678 ® & QR678 ® Neo as monotherapy and as combination therapy with 5% Minoxidil solution and oral Finasteride in the treatment of male androgenetic alopecia—Which is better?'
| Autor: | Debraj Shome, Komal Doshi, Ghanshyam Patel, Sapna Vadera, Rinky Kapoor, Vaibhav Kumar |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
integumentary system Combination therapy business.industry Dermatology medicine.disease Hair growth Food and drug administration 030207 dermatology & venereal diseases 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Hair loss chemistry Minoxidil 030220 oncology & carcinogenesis otorhinolaryngologic diseases Finasteride Medicine sense organs business Topical minoxidil medicine.drug |
| Zdroj: | Journal of Cosmetic Dermatology. 20:1763-1765 |
| ISSN: | 1473-2165 1473-2130 |
| Popis: | Hair is an essential aspect of image and is correlated with youth, elegance, fitness and achievement. Hair loss leads to lowered self-esteem, lack of confidence and depression amongst affected individuals. The US Food and Drug Administration (FDA) permitted management options for male Androgenetic Alopecia (AGA) are topical Minoxidil and oral Finasteride. These agents are beneficial in controlling hair loss, but can only induce minimal new hair growth. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|